The Dutch company Crystallics was a pioneer in the field of solid state and under the name of Avantium Pharma (see History) developed a number of unique and proprietary technologies. These technologies include the vertical transmission X-ray powder diffraction technology with multiwell plate analysis and the proprietary ‘shaking' method of the well plate (x,y movement) which enables a much faster analysis of the samples. Crystallics is currently the only CRO which holds a license from the inventor to use these technologies.
These unique, proprietary technologies, together with a strong customer focus, make Crystallics a leader in solid form screening and selection, preformulation and formulation design (source: http://www.crystallics.com).
On Monday the 30th March 2015, Crystallics and Excelsus Structural Solutions have announced a cooperation agreement where Crystallics will promote ESS' synchrotron technology for solid state characterization of pharmaceutical substances and products.
Read more on http://www.crystallics.com/newsletter-march-2015
Meibergdreef 31, Amsterdam, 1105 AZ, THE NETHERLANDS
Phone: +31 20 820 2690
Fax: +31 20 820 2691